Evidence map›Paper›PMID 37240936›Full record

ArticleJournal of personalized medicine2023

Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study.

Sabrina Giguère, Stéphane Potvin, Mélissa Beaudoin, Laura Dellazizzo, Charles-Édouard Giguère, Alexandra Furtos, Karine Gilbert, Kingsada Phraxayavong, Alexandre Dumais

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sabrina GiguèreDepartment of Psychiatry and Addictology, University of Montreal, Montreal, QC H3T 1J4, Canada.
Stéphane PotvinDepartment of Psychiatry and Addictology, University of Montreal, Montreal, QC H3T 1J4, Canada.ORCID 0000-0003-1624-378X
Mélissa BeaudoinDepartment of Psychiatry and Addictology, University of Montreal, Montreal, QC H3T 1J4, Canada.ORCID 0000-0002-0169-8055
Laura DellazizzoDepartment of Psychiatry and Addictology, University of Montreal, Montreal, QC H3T 1J4, Canada.ORCID 0000-0001-8262-130X
Charles-Édouard GiguèreResearch Center of the University Institute in Mental Health of Montreal, Montreal, QC H1N 3V2, Canada.ORCID 0000-0002-8507-6412
Alexandra FurtosDepartment of Chemistry, University of Montreal, Montreal, QC H2V 0B3, Canada.
Karine GilbertDepartment of Chemistry, University of Montreal, Montreal, QC H2V 0B3, Canada.
Kingsada PhraxayavongResearch Center of the University Institute in Mental Health of Montreal, Montreal, QC H1N 3V2, Canada.ORCID 0000-0003-3113-9104
Alexandre DumaisDepartment of Psychiatry and Addictology, University of Montreal, Montreal, QC H3T 1J4, Canada.ORCID 0000-0002-4480-0064
Université de Montréal · CAInstitut national de psychiatrie légale Philippe-Pinel · CAMcGill University Health Centre · CA

Funding

Fondation Lévesque NAIRSC Catayseur CRS-2021-118Services et recherches psychiatriques AD NA
6 · The paper itself

Abstract

Cannabis use disorder (CUD) is a complex issue, even more so when it is comorbid with a severe mental disorder (SMD). Available interventions are at best slightly effective, and their effects are not maintained over time. Therefore, the integration of virtual reality (VR) may increase efficacy; however, it has not yet been investigated in the treatment of CUD. A novel approach, avatar intervention for CUD, uses existing therapeutic techniques from other recommended therapies (e.g., cognitive behavioral methods, motivational interviewing) and allows participants to practice them in real-time. During immersive sessions, participants are invited to interact with an avatar representing a significant person related to their drug use. This pilot clinical trial aimed to evaluate the short-term efficacity of avatar intervention for CUD on 19 participants with a dual diagnosis of SMD and CUD. Results showed a significant moderate reduction in the quantity of cannabis use (Cohen's d = 0.611,

Indexed as

addiction interventioncannabis use disordermood disorderpsychotic disorderrelational therapyvirtual reality therapy

Identifiers

PMID37240936
PMCPMC10223054
OpenAlexW4367627315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.